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Abstract
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Researchers designing clinical trials often specify usual care received by participants as the control
condition expecting that all participants receive usual care regardless of group assignment. The
assumption is that the groups in the study are affected similarly. We describe the assessment of
usual care within the 16 studies in MACH 14, a multi-site collaboration on adherence to
antiretroviral therapy. Only five of the studies in MACH 14 assessed usual care. Assessment
protocols varied as did the timing and frequency of assessments. All usual care assessments
addressed patient education focused on HIV, HIV medications, and medication adherence. Our
findings support earlier work that calls for systematic assessments of usual care within the study
design, inclusion of descriptions of usual care in reports of the study, and the influence of usual
care on the experimental condition in clinical trials.
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Investigators conducting clinical trials often specify that the usual health care provided to
patients who participate in those trials is the control condition. A basic assumption
underlying these trials is that all participants in the study, regardless of their study group
assignment. continue to receive the usual care provided within the clinical setting.
Differences detected in the outcomes at the end of the study are expected to be due to the
experimental condition used in the study since that is what is different between the two or
more groups (Hulley, Cummings, Browner, Grady, & Newman, 2007). However, during the
study, when there is new evidence, there is the distinct possibility that health care providers
may modify usual care. Thus, the assessment and influence of usual care become important
considerations when examining the outcomes of a study.

Assessing Usual Care

Author Manuscript

Wagner and Kanouse (2003) in their seminal discussion offered three reasons to assess usual
care when conducting clinical trials designed to examine the effect of an intervention on
adherence to antiretroviral therapy (ART) prescribed for HIV infected patients. First,
describing usual care, as well as the intervention is necessary for another practice setting to
determine whether the tested intervention has the potential to be adopted and effective
within a different setting. This is particularly important given the current focus on
translating research into practice (Glasziou et al., 2010). Additionally, in a multi-site study
differences in usual care may provide the explanation for the site differences that occurred in
regard to the outcomes. However, this explanation can only be offered when usual care is
consistently monitored at each of the participating sites. Lastly, health care providers who
are also the researchers may begin to change the management of patients in their practice
and knowingly or unknowingly provide different care to the participants in the usual care
arm. Although, Wagner and Kanouse (2003) focused their comments on ART adherence
research, they did not limit the monitoring of usual care to only those trials; they emphasized
the need to assess usual care in other studies that include a behavioral intervention.

Author Manuscript

Author Manuscript

Modifications in treatment guidelines in the clinical management of patients with HIV/AIDS
have advanced because of drug discoveries and the emergence of new evidence regarding
their effectiveness and impact on a patient's clinical outcomes (Panel on Antiretroviral
Guidelines for Adults and Adolescents, 2013). Such changes in the delivery of usual care
have the potential to affect the hypothesized outcomes in an ongoing study when the
changes are introduced. All patients who participate in the study receive what is deemed to
be usual care. However, these participants may not all receive the same usual care
depending on the rate of adoption of the revisions to treatment guidelines at the study site,
the level of adherence to the guidelines by the health care providers, and when the
participants were recruited into the study. Clearly, usual care is a dynamic condition in
which health care providers alter their management of patients based on the latest evidence.

In 2009, de Bruin, Viechtbauer, Hospers, Schaalma, and Kok called for investigators to
report usual care to improve the accuracy of the assessment of change that occurred as a
result of a behavioral intervention being tested within a clinical trial. Williams (2010)
supported this position stating that the components and processes occurring during usual
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care are important to the overall conduct of the clinical trial. When usual care is based on the
latest evidence, it may include components that are also within the behavioral intervention
that is being tested in the trial such as health teaching to promote better medication
management (de Bruin et al., 2010). The meta-analysis conducted by de Bruin and
colleagues (2010) showed that the intervention arm performed better when there was a lower
level of usual care provided. As the level of usual care increased and included more of the
components in the intervention, there was less effect demonstrated by the intervention being
tested (de Bruin et al., 2010; Williams, 2010).

Author Manuscript

Yet, investigators do not typically describe the usual care condition within the methods
section of a published paper raising questions regarding what is actually included in usual
care, whether usual care was monitored for any changes in delivery during the study, and
how changes in usual care may have affected the hypothesized outcomes (de Bruin et al.,
2009). Without this information the internal validity of the study is threatened (Polit &
Beck, 2012). Descriptions of usual care are even more problematic when a study uses
multiple sites because of possible variation in usual care across clinics and differences in
practices based on geographic location (Freedland, Mohr, Davidson, & Schwartz, 2011).
Also, whether individuals within a site or sites are randomized within a study needs to be
considered.

Author Manuscript

Despite the need for and value of assessing usual care, only a few methods for monitoring
the control condition in a study have been described (Carroll, 1997; Garland, Hurlburt,
Brookman-Frazee, Taylor, & Accurso, 2010). The use of a Theory Coding Scheme designed
to capture the components of the theory that are present in the interventions that are
delivered in an RCT could be extended to the systematic assessment of usual care (Michie,
Prestwich, & de Bruin, 2010). Similarly, the importance of assessing adherence to treatment
guidelines cannot be overlooked. Another possible usual care assessment, the Session
Report Form developed for a larger clinical trial, has been suggested by Kelley, Vides de
Andrade, Sheffer, and Bickman (2010). The form is completed by health care providers at
the end of a usual care session designed for youth being seen for mental health conditions to
inform the content addressed and the context in which usual care occurred. Possibly patients
could be informants about usual care; however, they may be unable to differentiate the usual
care provided to all patients in the clinic setting from the individualized care that they are
receiving.

Purpose
Author Manuscript

Although systematic assessment of usual care has clear advantages in clinical trials with a
behavioral intervention, usual care does not necessarily lend itself to rigorous, reliable, or
feasible assessment. To our knowledge no standard form for assessing usual care is
described in published studies. Additionally, there are few reports available to inform how
best to monitor usual care. This paper describes the assessment of usual care within the 16
studies of the MACH 14 (Multi-site Adherence Collaboration in HIV among 14 institutions)
collaborative group (Liu et al., 2013) and offers insight into current research practice using
those studies as examples when conducting and reporting results from clinical trials.
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Methods
Design
Data for this descriptive study examining the practice of assessing usual care were provided
by the sample of principal investigators within the MACH 14 collaboration and were
collected after the studies had ended. MACH 14 includes 16 NIH-funded studies conducted
at 14 different sites in various regions of the United States from 1997 to 2009. Each study
focused on medication adherence in patients with HIV/AIDS in which the outcome of
adherence in both the usual care/control and intervention arms was assessed using electronic
event monitors (Liu et al., 2013). All studies in MACH 14 received approval from their
respective organization's institutional review board.
Sample

Author Manuscript

Twelve of the 16 studies (75%) in MACH 14 were intervention studies Liu et al., 2013). The
length of the interventions within these studies varied from 5 to 23 weeks. The experimental
condition focused on improving medication adherence and directly or indirectly targeted the
participant's behavior. The interventions included one or more of the following components:
directly observed therapy, problem solving, counseling, feedback to the participant, peer
counseling, and feedback to the physician. Theories and models supporting the interventions
incorporated social cognitive theory, contingency management, self-regulation, and
motivational interviewing.
Data Collection

Author Manuscript

MACH 14 investigators initially provided a brief written summary of their intervention and
usual care/control study groups. Because these descriptions were rather general, we sought
more specific information regarding the assessment of usual care in the 16 studies. We
developed a questionnaire for the MACH 14 researchers to complete. If the researchers
answered “yes” that they monitored usual care, we asked them to describe how usual care
was assessed, when usual care was assessed, the frequency of the assessments, who
provided the assessment data, how the data were obtained, and the specific clinical practices
within usual care that were assessed. We also invited investigators to provide any additional
comments relevant to the assessment of usual care in their particular clinical settings.
Data Analysis
We reviewed each of the general descriptions of usual care provided by the MACH 14
researchers to get a sense of their use of the term “usual care”. We summarized the data
from the questionnaires using descriptive statistics, for example, frequencies and percents.

Author Manuscript

Results
The initial written descriptions showed that two-thirds (n=10) of the investigators identified
usual care as the “procedures provided to all patients”. However, when referring to the
control condition in their clinical trials, the researchers used diverse terms such as usual
care, standard clinic care, standard patient education, or comparison condition. While there
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was agreement regarding the definition of usual care, there was variability in how the
control condition was defined. Usual care was one example of the control condition.
Our findings showed that only one-third of the studies in Mach 14 (n=5) assessed usual care.
Responses to how usual care was assessed demonstrated that investigators in four of the
studies developed a study-specific form for assessing usual care. However, in the fifth study,
the researchers who were also the health care providers in that setting, stated that they were
familiar with the usual care practices and therefore did not conduct regular assessments of
usual care.

Author Manuscript

The frequency of the assessments of usual care varied. Four studies assessed usual care at
both the beginning and at the end of the study. Two of those four studies also monitored
usual care at 3 or 6 month intervals throughout the study. One study assessed usual care only
at the beginning; this study was the one where the health care porviders were also the
researchers. The investigators collected usual care data by telephone, face to face,
electronically, or mail. Most informants providing usual care assessment data were direct
care providers within the practice site. For the longitudinal studies that collected usual care
data more often, different personnel within the setting provided the information. Thus, there
was not continuity across informants.
The clinical practices within usual care that were assessed included HIV medical care
(referrals, laboratory monitoring, and physical examinations) and patient education related
to HIV infection, HIV medications, and medication adherence. Another practice in the
setting that was assessed was a patient's level of medication adherence when that individual
was seen for their clinic appointment.

Author Manuscript

Discussion
Recognizing the importance of the role of usual care in clinical trials, we set out to describe
the manner in which usual care was assessed within the 16 studies included in the MACH 14
collaboration as a means of showing the current research practice when conducting clinical
trials. The MACH14 sample included both intervention and non-intervention studies from
across the United States; these studies spanned nearly 15 years (Liu et al., 2013). During that
time there were new drug discoveries that changed antiretroviral treatment guidelines
potentially altering the usual care provided to patients with HIV participating in these
longitudinal studies (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013).

Author Manuscript

The findings available in this report demonstrate that there was limited systematic
monitoring of usual care in the trials included in MACH 14. MACH 14 was a convenience
sample of studies that assessed adherence to antiretroviral therapy using electronic event
monitors, as well as other bio-behavioral measures. The assessment of usual care was not a
criterion for a study's inclusion in MACH 14. The five studies monitoring usual care were
all intervention trials and each had assessments at the beginning of those studies; most
assessed usual care at the end of the study. Only a few studies assessed usual care at
intervals throughout the course of the study. Researchers in MACH 14 conducting non-
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intervention studies did not monitor usual care. However, the significance of usual care in
observational studies is no less important.
No consistent form for assessing usual care was used across the studies; each study
developed its own form. Only particular aspects of usual care within a practice setting may
have been included on the assessment form thus limiting the amount of information that was
obtained and that could be used to determine the role of usual care on the study outcomes.
While these studies attempted to capture any changes in usual care, having more objective
measures is preferred and makes tracking changes over time more precise.

Author Manuscript

Who provided the information about usual care may have affected the information that was
collected and made it challenging for the researcher to obtain objective and nonbiased data
about current clinic practices. There may have been a “Hawthorne effect” or a social
desirability effect when reporting data on usual care practices.
Because participants in some of the studies within MACH 14 were enrolled for 12 months or
longer and the interventions lasted between 5-23 weeks, there was the distinct possibility
that the usual care provided to participants may have differed by the time all participants
were enrolled into and completed a particular study. When usual care is monitored only at
the start of the study, it is not possible to know if any changes occurred in patient care
practices over the length of the investigation or whether the usual care began to include
aspects of the experimental condition. If participants are recruited from the community, as
well as clinics, it is not possible to gather data on usual care from all the practices where
participants received their care. Thus, the usual care received by participants recruited from
the community is unknown.

Author Manuscript

Our limited findings show that usual care assessments occurred intermittently, even those
that occurred at multiple time points within a study. With intermittent monitoring
assessments may not be done at the time an evidenced-based practice change was
introduced. Additionally, summarizing the common elements within usual care when there
are multiple health care providers in the practice setting is difficult as all providers may not
manage their patients in the same way. The variability of the available services and what
individual patients are offered and receive is difficult to capture within a standardized usual
care assessment form.

Author Manuscript

This brief report demonstrates the limited assessment of usual care within both clinical trials
and observational studies in MACH 14 supporting findings from earlier meta-analyses, as
well as commentaries calling for the need to assess usual care. How the assessment data was
used in the analyses within these studies is unknown. Assessing usual care is important to
understand the potential impact of changes in clinical practice during the length of a study.
A description of the usual care provided to study participants needs to be included when
reporting the study findings. Without a clear depiction of usual care, it becomes difficult to
make comparisons across studies and conduct systematic reviews or meta-analyses (de
Bruin et al., 2009).
This report suggests that there is a need to develop a protocol within the study to
systematically assess usual care throughout the study. Regardless of the research design a
West J Nurs Res. Author manuscript; available in PMC 2015 July 07.
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process similar to that for monitoring intervention fidelity should be considered
(Wickersham et al., 2011; Glasziou et al., 2010). Monitoring usual care throughout a study
and incorporating those data into the analysis will assist researchers to include the influence
of usual care on the outcomes of the study and offer changes in usual care as a potential
explanation for the findings in the study. Refer to Table 1 for the categories of assessment
and recommendations for monitoring usual care.
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Recommendations for Assessing Usual Care in Clinical Trials
Focal area

Recommendations

Study specific instrument

Develop a study specific form or modify a form so that it is specific to the study a priori
Consider developing a more detailed form rather than one that has broad categories in order to collect relevant
information
Include space for dates for any changes in clinic practices; provide space for identifying the changes
Include space for frequencies of ongoing events such as labs and follow-up appointments

Content

Include questions related to:
    Clinic visits including initial vs. follow-up, laboratory tests, physical examinations
    Usual frequency of clinic visits
    Referral services such as psychiatric -mental health or social service
    Special programs that are offered such as peer support groups

Author Manuscript

    Educational services such as review of medications, medication management/adherence, nutrition
    Programmatic and/or clinic changes including the nature of the change and date when the change occurred
    Other regular occurrences within the clinical management of patients
Study data collector

Identify usual care data collection as a specific position responsibility for a member of the research staff
Ensure that staff member has a clinical background
Prepare a study specific protocol for collecting usual care data
Provide training regarding the protocol for collecting usual care information
Conduct periodic quality assessments of usual care data collection
Conduct ant retraining of study staff, as necessary

Clinic Informant

Identify one consistent person from the healthcare agency/clinic who is knowledgeable about the clinic's practices
Provide training for the designated informant in order to ensure accurate and complete data collection

Timing

Collect data at the beginning, end, and at intervals during the study
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Track the date for each usual care data collection
Arrange a convenient date and time with the clinic informant for collecting usual care data
Mechanism

Collect data using an on-site face to face interview (preferred approach at least for the initial data collection)
Use telephone interview or electronic/mail data collection if unable to use on-site approach
Enter data into a database as soon after the data collection as possible
Contact the clinic informant to obtain any missing data or to clarify any of the information
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